Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Treasury Shares (2016 - 2025)

Immucell (ICCC) has disclosed Treasury Shares for 16 consecutive years, with $130760.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares fell 5.58% year-over-year to $130760.0, compared with a TTM value of $130760.0 through Sep 2025, down 5.58%, and an annual FY2024 reading of $138482.0, changed 0.0% over the prior year.
  • Treasury Shares was $59771.0 for Q3 2025 at Immucell, roughly flat from $59771.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $78173.0 in Q1 2021 and bottomed at $59771.0 in Q2 2025.
  • Average Treasury Shares over 5 years is $66817.4, with a median of $67301.0 recorded in 2022.
  • The sharpest move saw Treasury Shares decreased 16.02% in 2021, then increased 0.0% in 2023.
  • Year by year, Treasury Shares stood at $158171.0 in 2021, then fell by 6.92% to $147233.0 in 2022, then fell by 5.94% to $138482.0 in 2023, then changed by 0.0% to $138482.0 in 2024, then dropped by 5.58% to $130760.0 in 2025.
  • Business Quant data shows Treasury Shares for ICCC at $130760.0 in Q3 2025, $130760.0 in Q2 2025, and $138482.0 in Q1 2025.